直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

INCONTESTABLE® Blog

Ninth Circuit Provides Roadmap for Reverse Confusion Claims

July 31, 2017

Authored and Edited by Jonathan D. Uffelman; Naresh Kilaru; Julia Anne Matheson

On July 7, 2017, the Ninth Circuit issued a decision clarifying issues related to pleading and proving reverse trademark confusion claims.

Marketquest Group, Inc. sued BIC over use of the phrase “The WRITE Pen Choice for 30 Years” based on Marketquest’s rights in the mark “The Write Choice.”  The district court granted BIC’s motion for summary judgment, holding that although there was some likelihood of confusion, further analysis was unnecessary because fair use provided a complete defense to Marketquest’s infringement claims.

On appeal, the Ninth Circuit addressed several questions.  First, Marketquest argued that this was a reverse confusion case (where consumers dealing with a smaller senior user believe they are dealing with a larger junior user).  BIC argued that Marketquest’s complaint did not adequately plead reverse confusion.  The Ninth Circuit held that reverse confusion is not a separate claim that needs to be specifically plead, as long as reverse confusion is compatible with the theory of infringement alleged in the complaint.  Here, Marketquest had alleged that customers were confused “as to whether some affiliation, connection, or association exist[ed]” among BIC and Marketquest.  Because BIC had previously acquired smaller companies, the Court found it plausible that consumers might think BIC had acquired Marketquest.

Second, the Court discussed the evidence needed to establish intent in the reverse likelihood-of-confusion analysis.  The Court noted that no one type of evidence is required and detailed several indicia of intent a court might consider, such as evidence that a defendant: (1) deliberately intended to push the plaintiff out of the market by flooding the market with advertising; (2) knew or should have known of the plaintiff’s mark; (3) intended to copy the plaintiff; (4) failed to conduct a reasonably adequate trademark search; or (5) otherwise culpably disregarded the risk of reverse confusion.

The case is Marketquest Group, Inc. v. BIC Corp., Case No. 15-55755 (9th Cir. 2017)

Tags

fair use, Ninth Circuit

Related Practices

Trademark and Brand Management

Contacts

Jonathan D. Uffelman
Domain Name Specialist / Attorney
Washington, DC
+1 202 408 4328
Email
Naresh Kilaru
Partner
Washington, DC
+1 202 408 4236
Email

Copyright © 2017 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP